Faecal Calprotectin is a new biomarker which is helping to save money for the NHS by preventing unnecessary procedures on patients by screening out patients with IBS who do not require endoscopies.
The symptoms of functional disorders such as Irritable Bowel Syndrome (IBS) and organic inflammatory intestinal disease (IBD) can be very similar in presentation but are two very different medical conditions.
The New Faecal Calprotectin Care Pathway | NICE February 1, 2019
Big Changes Coming Soon to a Clinic Near You March 9, 2018
Launch of IBD Toolkit for GPs November 28, 2017